01.13.26 -- Allogeneic Cell Therapy's Success Hinges On Perfecting The Platform

AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Check out how cell line development and process optimization are advancing rAAV production.

Next generation sequencing technologies and workflow automation are accelerating genomic research. Understand key differences between sequencing methods and uncover strategies to boost efficiency.

Discover how T-cell culture media supplemented with key cytokines can maintain full functionality and support robust expansion for up to 12 days at room temperature.

Discover a streamlined dPCR-based workflow for precise lentiviral vector quantification to support safer, more consistent cell and gene therapies through accurate genome titer, VCN, and RCL assessment.

This expert panel breaks down the practical realities of today’s supply chain while forecasting how emerging technologies will redefine quality standards.

Gain insight into how early identification of CQAs can streamline mRNA drug product development, reduce risk, and align with evolving regulatory expectations.

Discover how innovations in closed-loop control and mechanical design extend peristaltic dosing limits to 2000 cP, maintaining accuracy while preserving the advantages of sterile, disposable paths.

A shift from traditional rocking motion systems to stirred-tank bioreactors can enhance T cell expansion, offering greater scalability and more intimate process control.

Uncover the best practices for cryopreserving small-volume advanced therapy medicinal products (ATMPs), emphasizing sterility, cell viability, and efficiency using innovative single-use systems and aseptic connectors.

N-1 perfusion enables higher inoculum densities, faster production, and reduced costs without altering fed-batch processes. Explore a practical path to intensification for biologics manufacturers.

By integrating automation into manufacturing workflows early, organizations can accelerate timelines, reduce resource strain, and build more reliable, scalable, and compliant production systems.

A growing number of AAV product developers are recognizing the value in moving to suspension as early in development as possible in order to optimize production.

Learn how innovative cell culture vessel design enables high-density cell growth with superior gas exchange and a closed system to scale up bioproduction efficiently while maintaining batch-to-batch consistency.